[1]

Rager O, Nkoulou R, Exquis N, et al. Whole-body SPECT/CT versus planar bone scan with targeted SPECT/CT for metastatic workup[J/OL]. Biomed Res Int, 2017, 2017: 7039406[2020-03-28]. https://www.hindawi.com/journals/bmri/2017/7039406/. DOI: 10.1155/2017/7039406.
[2] Guezennec C, Keromnes N, Robin P, et al.  Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patients[J]. Cancer Imaging, 2017, 17(1): 16-.   doi: 10.1186/s40644-017-0118-4
[3] 张雪辉, 孔飚, 肖国有, 等.  SPECT/CT显像对脊柱良恶性病变诊断的增益价值[J]. 中华核医学与分子影像杂志, 2016, 36(2): 156-160.   doi: 10.3760/cma.j.issn.2095-2848.2016.02.013
Zhang XH, Kong B, Xiao GY, et al.  The added value of SPECT/CT imaging for diagnosing benign and malignant lesions of spine[J]. Chin J Nucl Med Mol Imaging, 2016, 36(2): 156-160.   doi: 10.3760/cma.j.issn.2095-2848.2016.02.013
[4] 秦永德, 李肖红, 王塞岗, 等.  SPECT/CT骨显像在肿瘤患者可疑脊柱转移灶中的诊断价值[J]. 中华核医学杂志, 2008, 28(4): 249-251.   doi: 10.3760/cma.j.issn.2095-2848.2008.04.011
Qin YD, Li XH, Wang SG, et al.  The diagnostic value of SPECT/CT 99Tcm-MDP imaging in suspected bone metastasis[J]. Chin J Nucl Med, 2008, 28(4): 249-251.   doi: 10.3760/cma.j.issn.2095-2848.2008.04.011
[5] 张一秋, 石洪成, 顾宇参, 等.  99Tcm-MDP SPECT/CT骨显像对脊柱良恶性病变的鉴别诊断[J]. 中华核医学杂志, 2011, 31(3): 164-168.   doi: 10.3760/cma.j.issn.0253-9780.2011.03.005
Zhang YQ, Shi HC, Gu YS, et al.  Enhanced diagnostic value of 99Tcm-MDP SPECT/CT in patients with spinal bone malignancy[J]. Chin J Nucl Med, 2011, 31(3): 164-168.   doi: 10.3760/cma.j.issn.0253-9780.2011.03.005
[6] Helyar V, Mohan HK, Barwick T, et al.  The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate[J]. Eur J Nucl Med Mol Imaging, 2010, 37(4): 706-713.   doi: 10.1007/s00259-009-1334-3
[7] Teyateeti A, Tocharoenchai C, Muangsomboon K, et al.  A comparison of accuracy of planar and evolution SPECT/CT bone imaging in differentiating benign from metastatic bone lesions[J]. Med Assoc Thai, 2017, 100(1): 100-110.
[8] Utsunomiya D, Shiraishi S, Imuta M, et al.  Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT[J]. Radiology, 2006, 238(1): 264-271.   doi: 10.1148/radiol.2373041358
[9] 王善容, 丁月云, 朱宗平, 等.  SPECT/CT融合骨显像诊断肺癌单发骨转移的价值[J]. 山东大学学报: 医学版, 2018, 56(2): 41-46.
Wang SR, Ding YY, Zhu ZP, et al.  Validity of SPECT/CT bone fusing imaging in the diagnosis of single bone metastasis of lung cancer[J]. J Shandong Univ (Health Sci), 2018, 56(2): 41-46.
[10]

Beyer T, Freudenberg LS, Townsend DW, et al. The future of hybrid imaging —part 1: hybrid imaging technologies and SPECT/CT[J/OL]. Insights Imaging, 2011, 2(2): 161−169[2020-03-28]. https://insightsimaging.springeropen.com/articles/10.1007/s13244-010-0063-2. DOI: 10.1007/s13244-010-0063-2.
[11] Tuncel M, Ergun EL, Tuncali CM.  Clinical impact of SPECT-CT on bone scintigraphy in oncology: pattern approach[J]. J BUON, 2016, 21(5): 1296-1306.
[12] Brenner AI, Koshy J, Morey J, et al.  The bone scan[J]. Semin Nucl Med, 2012, 42(1): 11-26.   doi: 10.1053/j.semnuclmed.2011.07.005
[13] Lohrmann C, Hauschild O, Meyer PT, et al.  Hybrid imaging of peripheral skeletal disease by SPECT/high-resolution flat-panel CT[J]. J Nucl Med, 2013, 54(8): 1323-1326.   doi: 10.2967/jnumed.112.116343
[14] Lehman VT, Murphy RC, Maus TP.  99mTc-MDP SPECT/CT of the spine and sacrum at a multispecialty institution: clinical use, findings, and impact on patient management[J]. Nucl Med Commun, 2013, 34(11): 1097-1106.   doi: 10.1097/MNM.0b013e328364bfa6
[15] Haraldsen A, Bluhme H, Røhl L, et al.  Single photon emission computed tomography (SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer[J]. Clin Physiol Funct Imaging, 2016, 36(1): 40-46.   doi: 10.1111/cpf.12191
[16] Liu T, Wang SH, Liu H, et al.  Detection of vertebral metastases: a meta-analysis comparing MRI, CT, PET, BS and BS with SPECT[J]. J Cancer Res Clin Oncol, 2017, 143(3): 457-465.   doi: 10.1007/s00432-016-2288-z
[17] Jambor I, Kuisma A, Ramadan S, et al.  Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial[J]. Acta Oncol, 2016, 55(1): 59-67.   doi: 10.3109/0284186X.2015.1027411
[18] Ryoo HG, Lee WW, Kim JY, et al.  Minimum standardized uptake value from quantitative bone single-photon emission computed tomography/computed tomography for evaluation of femoral head viability in patients with femoral neck fracture[J]. Nucl Med Mol Imaging, 2019, 53(4): 287-295.   doi: 10.1007/s13139-019-00600-2
[19]

Tabotta F, Jreige M, Schaefer N, et al. Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases[J/OL]. BMC Musculoskelet Disord, 2019, 20(1): 619[2020-03-28]. https://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/s12891-019-3001-6. DOI: 10.1186/s12891-019-3001-6.
[20] Cook GJR, Goh V.  Molecular imaging of bone metastases and their response to therapy[J]. J Nucl Med, 2020, 61(6): 799-806.   doi: 10.2967/jnumed.119.234260
[21] Farkas I, Besenyi Z, Maráz A, et al.  Kezdeti tapasztalatok a 99mTc-PSMA-SPECT/CT-vel prosztatarákos betegekben[J]. Orv Hetil, 2018, 159(35): 1433-1440.   doi: 10.1556/650.2018.31128
[22] Parghane RV, Singh B, Sharma A, et al.  Role of 99mTc-methylene diphosphonate SPECT/CT in the detection of sacroiliitis in patients with spondyloarthropathy: comparison with clinical markers and MRI[J]. J Nucl Med Technol, 2017, 45(4): 280-284.   doi: 10.2967/jnmt.117.193094
[23] Ito S, Yamamoto Y, Tanii T, et al.  SPECT/CT imaging in ulnocarpal impaction syndrome[J]. Clin Nucl Med, 2013, 38(10): 841-842.   doi: 10.1097/RLU.0b013e31828da39d